Floppy infant syndrome
Dr. Kalpana Malla
MD Pediatrics
Manipal Teaching Hospital
Download more documents and slide shows on The Medical Post [ www.themedicalpost.net ]
Differentiating features according to site
of involvement
Site of involvement extent of weakness
Face arms legs
Central - + +
Anterior horn cell ++++ ++++
Peripheral nerve - +++ +++
Neuromuscular junction +++ +++ +++
Muscle Variable ++ +
Differentiating features according to site
of involvement
Site of involvement Proximal Vs distal weakness
Central ≥
Anterior horn cell ≥
Peripheral nerve <
Neuromuscular junction =
Muscle >
Differentiating features according to site
of involvement
Site of involvement Deep tendon R
Central N or ↑
Anterior horn cell absent
Peripheral nerve ↓↓/absent
Neuromuscular junction Normal
Muscle Decreased but +
Spinal muscular atrophies
• Degenerative diseases of motor neurons that
begin in fetal life and progress in infancy and
childhood
• AR inheritance, few AD, rare X-linked
• Incidence -1/25000
• 2nd most common NMD after DMD
Classification
• SMA type 1- Werdnig –hoffman disease (severe
infantile)
• SMA type 2 –late infantile slowly progressive
• SMA type 3 – kulenberg –welander disease-
chronic juvenile
Clinical features
• Generalized Severe hypotonia,
• Unable to feed
• Involve tongue face and jaw muscles but extra
ocular muscles and sphincters are spared
• Head lag
• Scarf sign-elbow crosses midline
• Respiratory distress at birth, Frequent respiratory
infections,
Clinical features
Unusual postures – Flaccid posture, frog
legged position
• Movements –muscle appear flabby. Weakness,
thin muscle mass, Decreased resistance to
passive movement of limbs and range of
movement of peripheral joints is increased
• Relative immobility
Clinical features
Absent tendon reflexes
• Delayed motor milestones
• Intelligence –normal
• Heart-not involved
• 2/3rd die by 2 yrs and many in early infancy
Myasthenia gravis
• Immune mediated
neuromuscular blockade.
• Blocking Ab produced
against acetyl choline
receptors on postsynaptic
membrane (anti Ach
receptor Abs)-Decreased
number of available Ach
receptors
Nicotinic action of Ach
On skeletal muscles – contracts Skeletal
muscles - ↑ tone and power
MG
• Have been reported in 1st yr of life
• Rare before 10 yrs
• F :M- 5:1
• Ocular muscle first affected – ptosis B/L
• Weak voice,swallowing & chewing difficult-
aspiration of secretions & saliva
• Lack of facial expression
• Inability to blow out cheeks
• Worst cases – muscles of limbs & respiration
are affected
• DTR – usually present
Neonatal transient MG
• Infants of myasthenic mothers
• Placental transfer of anti Ach Receptor -Abs
C/F:
Resp distress in first few hrs of life till 3 day
Hypotonia, generalized weakness
Weak suck, weak cry,dysphagia,choking and cyanosis
Ptosis
Less spontaneous movements
Resolves in 4 weeks but may persist for months
• Temporary
• Ptosis & paralysis of extraocular muscles are
apparently uncommon in neonatal
myasthenia
Juvenile myasthenia gravis
• After 10 yrs
• Ptosis-most common clinical finding-
it increases progressively as patients
are asked to sustain an upward gaze
for 30-90 sec
P - increases progressively as patients are
asked to sustain an upward gaze for 30-90
sec
Juvenile myasthenia gravis
• Extra ocular muscle weakness
• Diplopia
• Pupillary response –normal
• Dysphagia, dysarthria, facial weakness
• Infancy-feeding difficulties, poor head control
Juvenile myasthenia gravis
• Tendon reflexes may be diminished not lost
• Rapid fatigue of muscles
• Limb weakness-proximal or same on both limbs
• Symptomatic late in the day
• If untreated- progressive –resp muscle
involvement –risk of aspiration
• Prolonged course of remissions & relapses
Congenital MG
Hereditary not related to
maternal MG
Nearly permanent disorder
without spontaneous remission
Do not experience Myasthenia
crisis
Associations
• Occasionally secondary to hypothyroidism
usually Hashimoto thyroiditis
• Rheumatoid arthritis,SLE,Diabetes mellitus
• Thymomas noted in adults is rare in children
Diagnosis
• Edrophonium (Tenslon) test is diagnostic:
0.15-0.2mg/kg IV- marked improvement in
ptosis, and other muscle weaknesspositive is
symptoms improve
• Edrophonium – anticholine esterase,action
similar to neostigmine but transient in its effects
Diagnosis
• Electromyography-more specifically diagnostic
than muscle biopsy-decremental response to
repetitive motor nerve stimuli
• Antibody testing-circulating Ach R-antibody in
serum – positive in 80% cases - most specific
Treatment
• Mild cases- no treatment
• Cholinesterase-inhibiting drugs-
- pyridostigmine or alternative neostigmine
methyl sulfate - IM or Neostigmine bromide -
oral every 4-6 hrs-4-6weeks
Treatment
Immunosuppressive drugs – to reduce Ab to
acetylcholine receptors
- Prednisolone best - 4 wks then A/D dose for
6-8 months
-azathioprine,cyclosporine,cyclophophamide
have been used
Plasmapheresis ,IVIG- for refractory
cases,during myasthenia crisis